Statement: adverse events linked to either cardiac conditions or infections are not recorded in the primary or secondary clinical trial, but both do record episodes of epilepsy
Primary_evidence: Adverse Events 1:   Total: 0/655 (0.00%) Adverse Events 2:   Total: 0/580 (0.00%)
Secondary_evidence: Adverse Events 1:   Total: 0/15 (0.00%) Adverse Events 2:   Total: 0/16 (0.00%)